ALS patients present about four times higher levels of circulating Irisin compared to healthy controls, and Irisin is significantly associated with disease severity, respiratory function decline, and free fat mass level in ALS patients, particularly those with a hyper-metabolic status [140]. The gene discussed is FNDC5; the disease is amyotrophic lateral sclerosis.